Iterum Therapeutics plc Quarterly Debt-to-equity in % from Q1 2019 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Iterum Therapeutics plc quarterly Debt-to-equity history and growth rate from Q1 2019 to Q4 2024.
Iterum Therapeutics plc Debt-to-equity for the quarter ending December 31, 2024 was -389 %, a 159% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	-389	-1.05K	-159%	Dec 31, 2024
Q3 2024	-317	-592	-215%	Sep 30, 2024
Q2 2024	-598	-784	-422%	Jun 30, 2024
Q1 2024	-6.96K	-7.08K	-5832%	Mar 31, 2024
Q4 2023	658	+562	+589%	Dec 31, 2023
Q3 2023	275	+190	+225%	Sep 30, 2023
Q2 2023	186	+106	+133%	Jun 30, 2023
Q1 2023	121	+30	+32.8%	Mar 31, 2023
Q4 2022	95.4	-31.2	-24.7%	Dec 31, 2022
Q3 2022	84.7	-253	-74.9%	Sep 30, 2022
Q2 2022	79.7	+1.19K		Jun 30, 2022
Q1 2022	91.4	+358		Mar 31, 2022
Q4 2021	127	+294		Dec 31, 2021
Q3 2021	337	+510		Sep 30, 2021
Q2 2021	-1.11K	-884	-392%	Jun 30, 2021
Q1 2021	-266	+243	+47.7%	Mar 31, 2021
Q4 2020	-168	-573	-141%	Dec 31, 2020
Q3 2020	-173	-287	-252%	Sep 30, 2020
Q2 2020	-226	-281	-510%	Jun 30, 2020
Q1 2020	-509	-543	-1608%	Mar 31, 2020
Q4 2019	406			Dec 31, 2019
Q3 2019	114			Sep 30, 2019
Q2 2019	55.1			Jun 30, 2019
Q1 2019	33.8			Mar 31, 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.